Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5 -/- mice, decreases plasma cholesterol and epididymal fat deposition.

Saved in:

Bibliographic Details
Title:	Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5 ^-/- mice, decreases plasma cholesterol and epididymal fat deposition.
Authors:	Veeravalli S; Department of Structural and Molecular Biology, University College London, London, United Kingdom., Varshavi D; Medway Metabonomics Research Group, University of Greenwich, Chatham Maritime, United Kingdom., Scott FH; Department of Structural and Molecular Biology, University College London, London, United Kingdom., Varshavi D; Medway Metabonomics Research Group, University of Greenwich, Chatham Maritime, United Kingdom., Pullen FS; Medway Metabonomics Research Group, University of Greenwich, Chatham Maritime, United Kingdom., Veselkov K; Department of Surgery and Cancer, Faculty of Medicine, Imperial College, London, United Kingdom., Phillips IR; Department of Structural and Molecular Biology, University College London, London, United Kingdom.; School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom., Everett JR; Medway Metabonomics Research Group, University of Greenwich, Chatham Maritime, United Kingdom., Shephard EA; Department of Structural and Molecular Biology, University College London, London, United Kingdom.
Source:	Frontiers in physiology [Front Physiol] 2022 Aug 08; Vol. 13, pp. 859681. Date of Electronic Publication: 2022 Aug 08 (Print Publication: 2022).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101549006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-042X (Print) Linking ISSN: 1664042X NLM ISO Abbreviation: Front Physiol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-042X
DOI:	10.3389/fphys.2022.859681